Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Long-QT syndromes are heritable diseases associated with prolongation of the QT interval on an electrocardiogram and a high risk of sudden cardiac death due to ventricular tachyarrhythmia. In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier I(Ks) current. METHODS: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene. We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells. With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes. RESULTS: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes. Individual cells showed a “ventricular,” “atrial,” or “nodal” phenotype, as evidenced by the expression of cell-type–specific markers and as seen in recordings of the action potentials in single cells. The duration of the action potential was markedly prolonged in “ventricular” and “atrial” cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects. Further characterization of the role of the R190Q–KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant negative trafficking defect associated with a 70 to 80% reduction in I(Ks) current and altered channel activation and deactivation properties. Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype. CONCLUSIONS: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes. The patient-derived cells recapitulated the electrophysiological features of the disorder. (Funded by the European Research Council and others.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ventricle beat rates showed a positive chronotropic response over the concentration range in both the NRVM and hiPSC-CM ventricles (Fig. 3c), as expected for healthy NRVM59, hiPSC-CM60, engineered hiPSC-CM cardiac tissues16, and human patients61.”
From A tissue-engineered scale model of the heart ventricle (2018) · cites this paper as [60]
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Previous studies using iPSC-derived cardiomyocytes from type-1 LQTS patients revealed that the mutation in KCNQ1 caused potassium ion channel dysfunction resulting in sarcolemmal deficiency [5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Tumorous cell lines, although able to proliferate, are often incorporated with unwanted genetic or chromosomal abnormalities, which might induce interference to the resulting outcomes [4,5].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
In the citing paper
“Models built with iPSC derivatives also demonstrate functional and phenotypic traits comparable to their human in vivo parallel [4,5,6].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [5]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., Croft, G. F., Saphier, G., Leibel, R., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,962
Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,459
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming
Jaenisch, R., & Young, R. (2008) · Cell · doi:10.1016/j.cell.2008.01.015 · Cited by 1,427
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Research works printed but not linked: 2
- Freund C, 2010, Neth Heart J, 18, 51
- Brunner M, 2008, J Clin Invest, 118, 2246
Cited by
Items 901–1,000 of 1,000
Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells
Ng, K., Law, C.-Y., & Tse, H. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041105 · Cited by 4
Wali, R., Xu, H., Cheruiyot, C., Saleem, H. N., Janshoff, A., Habeck, M., & Ebert, A. (2024) · Biological Chemistry · doi:10.1515/hsz-2024-0023 · Cited by 6
The role of iPSC research for insight into inherited arrhythmia conditions
Josvai, M. B., Anderson, C. L., & Eckhardt, L. L. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.03.2005 · Cited by 4
Eschenhagen, T., & Blankenberg, S. (2013) · Der Internist · doi:10.1007/s00108-012-3157-8 · Cited by 4
Reprogramming human endometrial fibroblast into induced pluripotent stem cells
Chen, Y., Liou, Y., Chang, C., Li, H.-Y., Chen, C.-Y., Twu, N.-F., Yen, M.-S., Chang, Y.-L., Peng, C., Chiou, S., et al. (2012) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2012.01.008 · Cited by 4
Stem Cell Therapy to Treat Heart Failure
Földes, G., & Harding, S. E. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-088504-9.00157-4 · Cited by 7
Zhu, T., Tang, H., Shen, Y., Tang, Q., Chen, L., Wang, Z., Zhou, P., Xu, F., & Zhu, J. (2016) · PubMed Central · Cited by 4
Oh, J. G., Dave, J. K., Kho, C., & Stillitano, F. (2020) · Journal of Visualized Experiments · doi:10.3791/60135 · Cited by 4
Lahm, H., Heinrich, P. V., Zierler, E., Dzilic, E., Neb, I., Luzius, T., Doppler, S. A., Schneider, S., Lange, R., Krane, M., et al. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102691 · Cited by 4
Recent Technological Innovations to Promote Cardiovascular Research
Yuasa, S. (2022) · Circulation Journal · doi:10.1253/circj.cj-21-0978 · Cited by 4
Base Editing of Human Pluripotent Stem Cells for Modeling Long QT Syndrome
Wu, F., Guo, T., Sun, L., Li, F., & Yang, X. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10324-6 · Cited by 6
Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine
Parrotta, E. I., Scalise, S., Scaramuzzino, L., & Cuda, G. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pamb.1.2020.8 · Cited by 4
Association of the P441L KCNQ1 variant with severity of long QT syndrome and risk of cardiac events
Lu, H., Wen, D., Xiao, H., Dai, M., Xue, Y., Jia, Z., Guo, J., Wu, M., Shen, B. Q., & Zhao, R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.922335 · Cited by 4
Investigating Inherited Heart Diseases Using Human Induced Pluripotent Stem Cell-Based Models
Wang, B. (2024) · Life · doi:10.3390/life14111370 · Cited by 4
Advances in the development and use of human tissue-based techniques for drug toxicity testing
Clotworthy, M., & Archibald, K. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.802770 · Cited by 4
Nos3−/− iPSCs model concordant signatures of in utero cardiac pathogenesis
Campbell, K. A., Li, X., Biendarra‐Tiegs, S. M., Terzic, A., & Nelson, T. J. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.08.021 · Cited by 4
Action Potential Shape Is a Crucial Measure of Cell Type of Stem Cell-Derived Cardiocytes
Bett, G. C. L., Kaplan, A. D., & Rasmusson, R. L. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2015.11.026 · Cited by 4
Inheritable Potassium Channel Diseases
Amin, A. S., & Wilde, A. A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00052-3 · Cited by 4
Paying the Toll in Nuclear Reprogramming
Liu, C., Himmati, F., & Sayed, N. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00070 · Cited by 4
Chun, Y. W., Durbin, M. D., & Hong, C. C. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0984-9 · Cited by 5
Free Dermal Fat Autografting for Complex Craniofacial Wounds
Dufresne, C. R., & Poling, M. I. (2020) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000006398 · Cited by 4
Current development in iPSC-based therapy for autoimmune diseases
Kumar, A., Das, J. K., Peng, H., Wang, L., Ren, Y., Xiong, X., & Song, J. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822229-4.00001-2 · Cited by 4
Pluripotent Stem Cells for Cell Therapy
Schroeder, I. S. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1225-5_2 · Cited by 5
Lee, E. J., & Hitscherich, P. G. (2017) · Wiley eBooks · doi:10.1002/9783527689934.ch13 · Cited by 4
Rohner, E., Witman, N., Sohlmér, J., Genst, E. D., Louch, W. E., Sahara, M., & Chien, K. R. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00362-8 · Cited by 5
Malik, S., & Dhasmana, A. (2021) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-78101-9_5 · Cited by 4
Clinical and functional characterisation of a recurrent KCNQ1 variant in the Belgian population
Sieliwończyk, E., Alaerts, M., Simons, E., Snyders, D. J., Nijak, A., Vandendriessche, B., Schepers, D., Akdeniz, D., Craenenbroeck, E. M. V., Knaepen, K., et al. (2023) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-02618-4 · Cited by 4
Lysosomal signalling pathways influence heart rhythm, and regulate atrial function
Akerman, E., Burton, R. A. B., Rog‐Zielinska, E. A., Winbo, A., Aston, D., Falter, F., Mu-u-min, R., Read, M. J., Bose, S. J., Swietach, P., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag207 · Cited by 4
Reza, A. M. M. T., Lee, S., Shiwani, S., & Singh, N. K. (2014) · Cell Biology International · doi:10.1002/cbin.10407 · Cited by 4
Nuclear reprogramming to treat retinal degenerative diseases
Osakada, F. (2011) · Inflammation and Regeneration · doi:10.2492/inflammregen.31.33 · Cited by 4
A glimpse at cardiac ion channel macromolecular complexes
Balse, E., & Hatem, S. N. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu110 · Cited by 4
Induced Pluripotent Stem Cells from Polycystic Kidney Disease Patients
Hofherr, A., & Köttgen, M. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070767 · Cited by 4
Carpenedo, R. L., Julian, L. M., & Stanford, W. L. (2016) · Methods · doi:10.1016/j.ymeth.2016.04.012 · Cited by 4
Methods for Generating Self-Organizing Human Patterned Heart Organoids Using Pluripotent Stem Cells
Volmert, B. D., & Aguirre, A. (2024) · Methods in molecular biology · doi:10.1007/7651_2024_545 · Cited by 4
Cattelan, G., Altomare, C., Gentile, G., Lavdas, A. Α., Frommelt, L. S., Volani, C., Foco, L., Girardi, P., Peducci, E., Gerbolés, A. G., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.03.034 · Cited by 3
Models of the human heart for biomedical research: Opportunities and challenges
Streckfuß‐Bömeke, K., Zelarayan, L. C., Schnabel, R. B., Kränkel, N., Maack, C., Eschenhagen, T., Kappler, H. E., Klingmüller, U., Kramann, R., Loewe, A., et al. (2026) · Physiological Reports · doi:10.14814/phy2.70845 · Cited by 3
Khudiakov, A. A., Mura, M., Giannetti, F., Leonov, V., Alberio, C., Eskandr, M., Lonati, P. A., Borghi, M. O., Brink, P. A., Crotti, L., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag105 · Cited by 3
Diagnosis, Treatment, and Mechanisms of Long QT Syndrome
Wan, E. Y., & Marx, S. O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802002-9.00005-4 · Cited by 3
Current Status of Genome Editing in Cardiovascular Medicine
Termglinchan, V., Karakikes, I., Seeger, T., & Wu, J. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34148-4_7 · Cited by 4
Choi, D.-K., Kim, Y.-K., HoonYu, J., Min, S., & Park, S.-W. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.020 · Cited by 5
Establishment of an induced pluripotent stem cell line DHMi005-A from a healthy male proband
Dreßen, M., Luzius, T., Lahm, H., Neb, I., Doppler, S. A., Schneider, S., Dzilic, E., Lange, R., & Krane, M. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102662 · Cited by 3
Exosome-Derived microRNAs in Hypertrophic Cardiomyopathy
Wang, B. (2024) · Cardiogenetics · doi:10.3390/cardiogenetics14040019 · Cited by 4
Iñigo, I. H., Sridhar, A., Louradour, J., de la Cruz, A., Lundholm, S., Jauregi‐Miguel, A., Giannetti, F., Sala, L., Odening, K. E., Larsson, H. P., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70008 · Cited by 3
Cellular Therapy for the Infarcted Myocardium
Hartogh, S. C. D., Sluijter, J. P. G., Doevendans, P. A., & Laake, L. W. V. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-891-7_11 · Cited by 3
Induced pluripotent stem cells: progress towards a biomedical application
Barile, L., Altomare, C., & Zaza, A. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.123 · Cited by 3
Li, G., HE, X., & Sun, C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2668 · Cited by 3
Biomedical and social contributions to sustainability
Wilmut, I., Wongtawan, T., Quigley, M., & Sullivan, G. J. (2011) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2010.0370 · Cited by 5
Transformation to Inducible Pluripotent Stem Cells
Kodo, K., Ong, S., & Wu, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801888-0.00020-5 · Cited by 3
Herron, T. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00057-2 · Cited by 3
Calcified epicardial fat necrosis causing epicardial constriction
Nestelberger, T., Lange, R., Kühne, M., & Haaf, P. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz611 · Cited by 3
Iuso, A., Zhang, F., Rusha, E., Campbell, B., Dorn, T., Zanuttigh, E., Haas, D., Anikster, Y., Lederer, G., Pertek, A., et al. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102773 · Cited by 3
Self-citationSaleem, H. N., Ignatyeva, N., Stuut, C., Jakobs, S., Habeck, M., & Ebert, A. (2024) · Cells · doi:10.3390/cells13110923 · Cited by 3
Bruyneel, A. A. N., Muser, T., Parthasarathy, V., Feyen, D. A. M., & Mercola, M. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-20047-3_2 · Cited by 3
Bialecki, R., Lainée, P., & Valentin, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00718-1 · Cited by 3
Zhang, J., Qu, J., & Wang, J. (2014) · Europe PMC (PubMed Central) · Cited by 6
Clinical Application of Induced Pluripotent Stem Cells in Cardiovascular Medicine
Chi, H., Gao, S., Yang, X.-C., Cai, J., Zhao, W.-S., Sun, H., & Geng, Y. (2015) · Cardiology · doi:10.1159/000381280 · Cited by 5
Delineating nuclear reprogramming
Ooi, J., & Liu, P. (2012) · Protein & Cell · doi:10.1007/s13238-012-2920-x · Cited by 3
Vascular research using human pluripotent stem cells and humoral factors [Review]
Sone, M., & Nakao, K. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0020 · Cited by 3
Doing the dirty work: progress in the search for a reliable protocol for cardiomyogenesis
Redig, J. K., & Adler, E. (2011) · Stem Cell Research & Therapy · doi:10.1186/scrt76 · Cited by 3
Kaur, K. K., & Allahbadia, G. (2016) · Transcriptomics Open Access · doi:10.4172/2329-8936.1000134 · Cited by 3
Human Pluripotent Stem Cell‐Derived Cardiomyocytes
Shukla, P., Garg, P., & Wu, J. C. (2016) · Wiley eBooks · doi:10.1002/9781119053248.ch22 · Cited by 3
Advances in Umbilical Cord Blood Therapy: Hematopoietic Stem Cell Transplantation and Beyond
Chow, T., Mueller, S., & Rogers, I. M. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-29149-9_8 · Cited by 3
Amniotic fluid stem cell models: A tool for filling the gaps in knowledge for human genetic diseases
Stuppia, L., Antonucci, I., & Crowley, M. G. (2017) · Brain Circulation · doi:10.4103/bc.bc_23_17 · Cited by 3
hiPSC-Based Tissue Organoid Regeneration
Qu, Y., Yucer, N., Garcia, V. J., Giuliano, A. E., & Cui, X. (2018) · InTech eBooks · doi:10.5772/intechopen.76997 · Cited by 4
London, B. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382227-7.00051-3 · Cited by 3
Schwartz, P. J., & Crotti, L. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00093-5 · Cited by 3
Human iPSC models of cardiac electrophysiology and arrhythmia
Yang, B., Lowenthal, J., Tomaselli, G. F., & Tung, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85767-3.00006-2 · Cited by 5
Henze, S. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6012 · Cited by 3
Lahm, H., Dzilic, E., Neb, I., Doppler, S. A., Schneider, S., Lange, R., Krane, M., & Dreßen, M. (2023) · Stem Cell Research · doi:10.1016/j.scr.2023.103126 · Cited by 3
Integrating Macrophages into Human-Engineered Cardiac Tissue
Zhao, Y. P., & Fine, B. M. (2025) · Cells · doi:10.3390/cells14171393 · Cited by 2
Jiménez-Sábado, V., Babini, H., Ruben, P. C., Accili, E. A., Claydon, T. W., Hove‐Madsen, L., & Tibbits, G. F. (2025) · Cells · doi:10.3390/cells14241941 · Cited by 3
Nagashima, T., Miki, K., Tsuchida, M., Whitehouse, J., Sasozaki, I. T., Higashiyama, Y., Ishida, H., Kashino, K., & Miyagawa, S. (2026) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70108 · Cited by 2
Upadhyaya, P. (2026) · Stem Cells · doi:10.1093/stmcls/sxag039 · Cited by 2
Induced pluripotent stem cells from discovery to translation
Lee, J., Herron, T. J., Studer, L., Mummery, C. L., & Wu, J. C. (2026) · Nature Medicine · doi:10.1038/s41591-026-04584-3 · Cited by 3
Biomedical Applications of Induced Pluripotent Stem Cells
Selvaraj, V. (2011) · Springer eBooks · doi:10.1007/978-94-007-2415-0_27 · Cited by 3
Assessing the Arrhythmogenic Potential of New Drugs: A Guide for the Pharmaceutical Physician
Gunaruwan, P., & Howes, L. G. (2015) · Pharmaceutical Medicine · doi:10.1007/s40290-015-0082-x · Cited by 2
Modelling of Genetic Cardiac Diseases
Prajapati, C., & Aalto‐Setälä, K. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84965 · Cited by 2
Ahmed, R. E., Chanthra, N., Anzai, T., Koiwai, K., Murakami, T., Suzuki, H., Hanazono, Y., & Uosaki, H. (2021) · Journal of Visualized Experiments · doi:10.3791/62129 · Cited by 2
Dreßen, M., Lahm, H., Neb, I., Luzius, T., Doppler, S. A., Schneider, S., Dzilic, E., Lange, R., & Krane, M. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102617 · Cited by 2
Wang, L., Zeng, Q., Wang, S., Wu, D., Wang, J., Zhang, H., & Lv, X. (2023) · Stem Cell Research · doi:10.1016/j.scr.2023.103278 · Cited by 2
Ireland, J., & Kilian, K. A. (2024) · Matrix Biology Plus · doi:10.1016/j.mbplus.2024.100160 · Cited by 3
Mapping the landscape of PSC-CM research through bibliometric analysis
Li, J., Han, S., Yu, F., Li, T., Liao, B., & Liu, F. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1435874 · Cited by 2
Pavel, M. A., Chen, H., Hill, M., Sridhar, A., Barney, M., DeSantiago, J., Baskaran, A., Owais, A., Sandu, S., Darbar, F. A., et al. (2026) · eLife · doi:10.1101/2024.12.06.24318402 · Cited by 4
Opportunities and challenges for human microphysiological systems in drug development
Rahman, S. M., Krishna, A., Sullenberger, C., Jeong, Y. E., García, M., Bhardwaj, B., Geiger, R. M., Blinova, K., & Ford, K. A. (2024) · ALTEX · doi:10.14573/altex.2409221 · Cited by 15
Abdel-Malek, K., von Eisenhart-Rothe, F., Stiegmann, S., Gottmann, I., Doppler, S. A., Schneider, S., Preisler, H., Lahm, H., & Dreßen, M. (2025) · Stem Cell Research · doi:10.1016/j.scr.2025.103785 · Cited by 2
Evidence for Renal Progenitors in the Human Kidney
Lasagni, L., Lazzeri, E., Peired, A. J., & Romagnani, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800102-8.00029-1 · Cited by 2
Utility of Human Stem Cells for Drug Discovery
Chintawar, S., Graf, M. R., & Cader, M. Z. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782620136-00162 · Cited by 2
Technologies to Study Genetics and Molecular Pathways
Dorn, C., Grunert, M., Dopazo, A., Sánchez‐Cabo, F., Gatto, A., Vázquez, J., Sperling, S., & Lara‐Pezzi, E. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1883-2_18 · Cited by 2
Sakamoto, T., Nishimura, K., Ohnishi, H., & Iki, T. (2014) · Springer eBooks · doi:10.1007/978-4-431-54862-1_31 · Cited by 2
nismaa, R., Ylä‐Outinen, L., Jarno, E., & Narkilahti, S. (2011) · InTech eBooks · doi:10.5772/14912 · Cited by 2
Modeling Hereditary Cardiac Disease With Patient-specific-induced Pluripotent Stem Cells
Ng, K., & Tse, H. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31825f3f0f · Cited by 2
Inherited Arrhythmias: Of Channels, Currents, and Swimming
Zylla, M. M., & Thomas, D. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.02.010 · Cited by 2
Modeling Cardiac Congenital Diseases: From Mathematic Tools to Human Induced Pluripotent Stem Cells
Iop, L. (2014) · Conference Papers in Science · doi:10.1155/2014/369246 · Cited by 2
Modeling Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy with Patient-Specific iPSCs
Shah, K., Wei, C.-Y., Kim, C.-S., Wong, J., Wen, J., Tirasawasdichai, T., Wang, C., & Chen, H.-S. V. (2016) · Springer eBooks · doi:10.1007/978-4-431-55966-5_3 · Cited by 3
The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System
Bertin, E., Piccoli, M., Franzin, C., Nagy, A., Mileikovsky, M., Coppi, P. D., & Pozzobon, M. (2017) · Journal of Visualized Experiments · doi:10.3791/54598 · Cited by 2
Dirschinger, R. J., Dorn, T., & Moretti, A. (2019) · Cardiac and vascular biology · doi:10.1007/978-3-030-27371-2_10 · Cited by 2
Self-citationDasí, A., Hernández‐Romero, I., Gómez, J. F., Climent, A. M., Ferrero, J. M., & Trénor, B. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104796 · Cited by 3
Microelectrode Arrays: A Valuable Tool to Analyze Stem Cell-Derived Cardiomyocytes
Kussauer, S., David, R., & Lemcke, H. (2021) · Springer eBooks · doi:10.1007/978-3-030-77052-5_1 · Cited by 3
Wan, Z., Guan, J., Li, Y., Zhang, H., Wang, B., Yang, X., Jin, X., Ma, X., & Liu, Y. (2023) · Stem Cell Research · doi:10.1016/j.scr.2023.103139 · Cited by 2
Heijman, J. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120427jh · Cited by 3
Metadata
- Authors
- Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., Seyfarth, M., Sinnecker, D., Schömig, A., & Laugwitz, K.-L.
- Affiliations
- TUM Klinikum (DE)
- Deutsches Herzzentrum München (DE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-07
- Volume
- 363
- Issue
- 15
- Pages
- 1397-1409
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2104996733
- Cited by
- 1,251
- References
- 40
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 43 · 2023: 49 · 2022: 51 · 2021: 79 · 2020: 56 · 2019: 69 · 2018: 69 · 2017: 89 · 2016: 90 · 2015: 111 · 2014: 90 · 2013: 116 · 2012: 143
- FWCI
- 88.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- LQT1, KCNQ1, induced pluripotent stem cells, patient-specific disease models, cardiomyocyte differentiation, action potential prolongation, delayed rectifier potassium current, beta-adrenergic blockade, sudden cardiac death, ventricular repolarization
- MeSH terms
- Kruppel-Like Factor 4, Action Potentials, Adrenergic beta-Antagonists, Adult, Aged, Cardiotonic Agents, Child, Female, Fibroblasts, Humans, Isoproterenol, Male, Pedigree, Phenotype, Potassium Channels, Gene Expression, Mutation, Missense, Reverse Transcriptase Polymerase Chain Reaction, Potassium Channel Blockers, Romano-Ward Syndrome, Myocytes, Cardiac, KCNQ1 Potassium Channel, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.